LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases–a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.

Schimanski, C.C., Mohler, M., Schon, M., van Cutsem, E., Greil, R., Bechstein, W.O., Hegewisch-Becker, S., von Wichert, G., Vohringer, M., Heike, M., Heinemann, V., Peeters, M., Kanzler, S., Kasper, S., Overkamp, F., Samonigg, H., Seehofer, D., Kullmann, F., Schmidtmann, I., Smith-Machnow, V., Gockel, I., Lang, H., Galle, P.R., 2012.

BMC Cancer 12, 144. doi:10.1186/1471-2407-12-144

Studie: LICC; Indikation: Kolorektalkarzinom; Jahr: 2012; Veranstaltung: -; Journal: BMC Cancer

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com